Yasushi Magami

Positive Modulation of IL-12 Signaling by Sphingosine Kinase 2 Associating with the IL-12 Receptor β1 Cytoplasmic Region

IL-12 is a key immunoregulatory cytokine that promotes Th1 differentiation and cell-mediated immune responses. IL-12 stimulation results in the activation of Janus kinase 2 and tyrosine kinase 2 and, subsequently, STAT4 and STAT3. In addition, mitogen-activated protein kinase kinase 6/p38 mitogen-activated protein kinase and phosphatidylinositol 3-kinase/Akt pathways have been recently demonstrated to be activated by IL-12 and play an important role in IL-12 signaling. To further elucidate the molecular mechanism underlying IL-12 signaling, we have performed a yeast two-hybrid screening and identified mouse sphingosine kinase 2 (SPHK2) as a molecule associating with the mouse IL-12Rβ1 cytoplasmic region. Analyses of various mutants of each molecule revealed that the region including the proline-rich domain in SPHK2 is probably responsible for the binding to IL-12Rβ1, while the regions including the carboxyl terminus and Box II in the IL-12Rβ1 cytoplasmic region appear to be involved in the binding to SPHK2. Transient expression of wild-type SPHK2 in T cell hybridoma augmented IL-12-induced STAT4-mediated transcriptional activation. Ectopic expression of dominant-negative SPHK2 in Th1 cell clone significantly reduced IL-12-induced IFN-γ production, while that of wild-type SPHK2 enhanced it. In contrast, the expression minimally affected IL-12-induced proliferation. A similar decrease in IL-12-induced IFN-γ production was observed when dominant-negative SPHK2 was expressed in activated primary T cells using a retroviral expression system. These results suggest that SPHK2 associates with the IL-12Rβ1 cytoplasmic region and probably plays a role in modulating IL-12 signaling.

Synergistic antitumor effect by coexpression of chemokine CCL21/SLC and costimulatory molecule LIGHT.

To establish a more efficient treatment for immunotherapy against solid tumors, we have evaluated the antitumor effect by coexpression of a chemokine CCL21/secondary lymphoid tissue chemokine and a costimulatory molecule LIGHT in colon carcinoma C26. C26 cells expressing either CCL21 or LIGHT exhibited a significantly reduced tumor growth in vivo, and mice inoculated with these cells showed a prolonged survival, but eventually all these mice died. In contrast, C26 cells expressing both CCL21 and LIGHT exhibited a minimal tumor growth in vivo, and all these mice survived healthily with a tumor remission and consequently acquired a strong protective immunity. A markedly increased infiltration of mature dendritic cells (DCs), and CD8+ T cells was observed in the tumor mass, and their spleen cells showed a greatly enhanced cytotoxic T lymphocyte (CTL) activity against C26 tumor and interferon (IFN)-γ production. Neutralization of IFN-γ or depletion of CD8+ or CD4+ T cells significantly reduced the antitumor activity. These results suggest that the combined treatment with CCL21 and LIGHT is able to induce a synergistic antitumor effect to eradicate tumor completely by greatly enhancing tumor-infiltration of lymphocytes including mature DCs and CD8+ T cells, resulting in markedly augmented CTL activity and IFN-γ production.

Heterogeneous Cell Renewal of Pancreas in Mice : [^3H]-thymidine Autoradiographic Investigation

Introduction Although cell kinetics of the gastrointestinal mucosa has been extensively examined, that of the pancreas has not been fully analyzed. Aim To determine the renewal rate of pancreatic cells directly. Methodology Postnatal proliferative activity and cellular renewal of the parenchymal cells in ICR mouse pancreas were studied by immunohistochemistry and [3H]thymidine autoradiography. Results In the single labeling experiments, the proliferative activity of the parenchymal cells in pancreas showed peaks at a few days after birth, decreased thereafter, and reached a low level at 2 months after birth. Continuous labeling experiments revealed that, in the adult pancreas, the half lives of acinar cells, islet cells, and duct epithelial cells were approximately 70 days, 47 days, and 40 days, respectively. Moreover, in the exocrine pancreas, acinar cells of the peri-insular region proliferated more actively than those of the tele-insular region. The renewal rate of glucagon cells was more rapid than that of insulin cells or somatostatin cells. Large ducts showed a high rate of cell renewal in comparison with small ducts. Conclusion The results of this study indicate that cell renewal rates of the pancreas are not homogeneous, but heterogeneous.

A case of hemangioma accompanied by inflammatory pseudotumor of the spleen.

Both hemangioma and inflammatory pseudotumor (IPT) of the spleen are rare benign mass lesions. Moreover, a splenic hemangioma accompanied by IPT is extremely rare. A 61-year-old woman who suffered from liver cirrhosis had a splenic cavernous hemangioma surrounded by granuloma. The literature on IPT of the spleen has described several possibilities of its causes; however, it is still unknown. This case was accompanied by portal hypertension due to liver cirrhosis, which may cause microrupture of hemangioma resulting in an IPT.

Cell kinetics of slow renewing cell populations in mice stomach

Backgorund: The renewal rates of parietal and chief cells in the gastric mucosa and smooth muscle cells of muscularis propria have not been examined as precisely as superficial epithelial cells. To examine cell renewal of these cells, continuous labeling with tritiated ([3H])‐thymidine was performed.

Proliferation and Functional Changes of Pancreatic Gastrin Cells in Neonatal Rat

Introduction Although gastrin cells are not found in the adult pancreas, they are found transiently in the neonatal pancreas. It has been suggested that gastrin may play a role in pancreatic development. However, cell kinetics as well as the fate and the role of gastrin cells are not clear. Methodology Proliferation and functional changes of pancreatic gastrin cells in neonatal Wister rats were studied by immunohistochemistry and [ 3 H]thymidine autoradiography. Results Numbers of pancreatic gastrin cells in neonatal rats showed a peak immediately after birth and then decreased rapidly. Gastrin cells were observed within approximately 2 weeks after birth in islets and within approximately 4 weeks after birth among exocrine cells. In contrast with the decrease of gastrin cell numbers, numbers of duodenal cholecystokinin cells increased remarkably after 7 days of age. Proliferative activity of acinar cells showed two peaks at age 2 days and 9 days. Despite a decrease in gastrin cell numbers, gastrin cells maintained a certain degree of proliferative activity. The “re-staining method” for gastrin and insulin revealed that immunoreactive cells for both gastrin and insulin were rarely found a few days after birth. Conclusion These results suggest that pancreatic gastrin cells do not die off or change to another type of endocrine cell and that some gastrin cells change to insulin cells.

Overexpression of cyclin A and p53 in hepatocellular carcinomas. Wild P53 downregurate cyclin a promoter activity

Backround: The p16 INK4a tumor suppressor gene induces a cell cycle G1 arrest. It is the second most commonly inactivated gene identified in human cancers after p53. The p16 gene has been shown to be inactivated in nearly all human colon cancer cell lines and half of colon cancers and adenomas. While the p16 gene has been demonstrated to be inactivated primarily by promoter DNA methylation in hepatocellular carcinomas, there have been no studies examining p16 expression in premalignant liver lesions . Design: 17 macroregenerative and dysplastic nodules and 2 hepatocellular carcinomas from 15 hepatectomy specimens in patients undergoing transplantation for hepatitis C cirrhosis were examined by immunohistochemistry and methylation sensitive polymerase chain reaction (PeR). The nodules were less than 2 cm in diameter and clinically undetected . Sections were stained with anti-human pl6 monoclonal antibody . Human sporadic colon adenocarcinomas served as positive controls . Staining for p16 was considered positive if nuclear staining was greater than cytoplasmic staining. Methylation sensitive PCR was performed on bisulfite-treated DNA extracted from microdissected paraffin sections. Results: No nuclear staining was detected in the macroregenerative or dysplastic nodules. Two nodules demonstrated weak cytoplasmic staining . The surrounding cirrhotic liver showed cytoplasmic and no nuclear staining . Bile ductules at the margins of the nodules showed positive staining and served as internal positive controls. The 2 hepatocellular carcinomas showed a distinct lack of nuclear or cytoplasmic staining. Negative controls lacked cytoplasmic and nuclear staining. One hepatocellular carcinoma and two macroregenerative nodules had methylated p16 gene promoters , while two of the surrounding cirrhotic liver samples had unmethylated pl6 gene promoters. One macroregenerative nodule also showed evidence of both methylated and unmethylated pl6 forms. Conclusions: In patients with hepatitis C, clinically undetected macroregenerative and dysplastic nodules show an absence of pl6 staining. It is likely that pl6 gene methylation is responsible for suppression ofpl6 expression in these nodules. This supports previous observations that a high percentage of hepatocellular carcinomas have inactive p16 genes and suggests that p16 inactivation occurs early in liver tumor progression.